Shares of Merck & Co. (NYSE:MRK) were the recipient of unusually large options trading on Tuesday. Stock investors acquired 25,085 call options on the company, Analyst Ratings Net reports. This represents an increase of 131% compared to the typical daily volume of 10,855 call options. Merck & Co., Inc. (NYSE:MRK) stock opened at $57.35 in last session, and closed at $57.47, while the day range of Merck & Co., Inc. (NYSE:MRK) stock is $57.10 – $57.57. The stock showed a positive weekly performance of 0.84%.
Johnson & Johnson (NYSE:JNJ) is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field. The business of Johnson & Johnson is conducted by more than 275 operating companies located in 60 countries, including the United States, which sell products in virtually all countries throughout the world. Johnson & Johnson (NYSE:JNJ) stock opened at $93.37 in last session, and closed at $93.32 by gaining 0.46%. The 52 week range of $77.70 – $95.99. Company’s market capitalization is $263.16 billion.
AbbVie Inc. (ABBV) presented the first detailed results from the PEARL-III pivotal phase III study on its investigational hepatitis C virus (HCV) infection therapy at the Retroviruses and Opportunistic Infections (:CROI) press conference. AbbVie’s oral investigational regimen comprises a fixed-dose combination of ABT-450 co-formulated with ABT-267 (once daily) and ABT-333 with or without ribavirin (RBV), administered twice daily. AbbVie Inc. (NYSE:ABBV) stock decreased -1.11% and finished the last session at $51.46. The EPS of the stock remained 2.57. Company’s market capitalization is $81.92 billion.
Bristol-Myers Squibb (NYSE:BMY) Director James M. Cornelius unloaded 100,000 shares of Bristol-Myers Squibb stock on the open market in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $55.82, for a total value of $5,582,000.00. Following the sale, the director now directly owns 273,393 shares of the company’s stock, valued at approximately $15,260,797. Bristol-Myers Squibb Co (NYSE:BMY) stock opened the session at $55.73, and closed the session at $55.83. The 52 week range of the Bristol-Myers Squibb Co (NYSE:BMY) stock remained $37.26 – $57.49 and the day range was $54.87 – $55.91.